Macopharma press release: German Red Cross NSTOB Springe implements the THERAFLEX MB-Plasma Pathogen Reduction System (2011)

News Report · Macopharma SA (company press release) · September 27, 2011

Macopharma SA (company press release), 2011-09-27: Company press release announcing routine use of the methylene blue plasma system at a German Red Cross blood centre, stating the Class III CE mark and that the system is not for sale in the United States.

The THERAFLEX MB-Plasma System has a Class III CE Mark (available for sale in countries where the CE mark is accepted) and is not currently available for sale in the United States.

3 (PDF page 3)

Macopharma SA (company press release), 2011-09-27: Company press release announcing routine use of the methylene blue plasma system at a German Red Cross blood centre, stating the Class III CE mark and that the system is not for sale in the United States. Manufacturer: Macopharma. States more than 4.5 million MB-treated plasma units transfused worldwide and 2.5 million treated with THERAFLEX. document_date from the release dateline (LILLE, FRANCE – September 27th 2011). Copyright Macopharma; hosted copy at transfusion.ru is a republication. The CE mark is a European device certification, not an FDA approval. Study type: news.